STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Haemonetics (NYSE: HAE) has announced the availability of its first quarter fiscal year 2025 financial results on its Investor Relations website. The company will host a conference call and webcast on August 8, 2024, at 8:00 a.m. ET to discuss the results with investors and analysts. Participants can access the call via a teleconference link or a live webcast. The earnings release referenced during the call is also available on the company's website. A replay of the conference call and webcast will be accessible for one year starting from August 8, 2024, at 11:00 a.m. ET.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Financial release accessible online

BOSTON, Aug. 8, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2025, which ended June 29, 2024, are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 8, 2024. The conference call and webcast can be accessed with the following information:

In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.

Direct link to 1Q FY25 Earnings Release:
https://haemonetics.gcs-web.com/static-files/1048427c-6709-4f0f-95d3-099b50780c50

A replay of the conference call and webcast will be available for one year beginning on August 8, 2024, at 11:00 a.m. ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:             


Olga Guyette, Vice President-Investor Relations & Treasury

David Trenk, Manager-Investor Relations

(781) 356-9763                    

(203) 733-4987

olga.guyette@haemonetics.com          

david.trenk@haemonetics.com                                                                               



Media Contact:                                   


Josh Gitelson, Sr. Director-Global Communications       


(781) 356-9776


josh.gitelson@haemonetics.com 


Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-1st-quarter-fiscal-year-2025-earnings-release-available-on-investor-relations-website-302217606.html

SOURCE Haemonetics Corporation

FAQ

When will Haemonetics (HAE) release its Q1 FY2025 earnings?

Haemonetics (HAE) has already released its Q1 FY2025 earnings, which are available on the company's Investor Relations website as of August 8, 2024.

When is Haemonetics (HAE) hosting its Q1 FY2025 earnings call?

Haemonetics (HAE) is hosting its Q1 FY2025 earnings call on August 8, 2024, at 8:00 a.m. ET.

How can investors access Haemonetics (HAE) Q1 FY2025 earnings call?

Investors can access Haemonetics (HAE) Q1 FY2025 earnings call via a teleconference link or a live webcast available on the company's Investor Relations website.

For how long will the replay of Haemonetics (HAE) Q1 FY2025 earnings call be available?

The replay of Haemonetics (HAE) Q1 FY2025 earnings call will be available for one year, beginning on August 8, 2024, at 11:00 a.m. ET.
Haemonetics Corp Mass

NYSE:HAE

HAE Rankings

HAE Latest News

HAE Latest SEC Filings

HAE Stock Data

3.92B
46.23M
1.15%
115.65%
7.61%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
BOSTON